Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Molecular Mechanisms of Cell Migration
Adolescent Substance Abuse: Progressive Treatment
Analysis of sarcoidosis, T-cell dependent antigens
Modulation of Humoral Immunity by Antiig Dextran
New Technology for Improving High Mass Ion Detection
Recently added grants:
Multipronged approach to promote functional axonal regeneration in the spinal cord after injury
Maladaptive compensatory plasticity in developing cortical circuits
Mechanisms of RNA and Protein Dysregulations in ALS/FTD Associated with FUS and Ubiquilin 2
Validation of Serum Neurofilament Light Chain as a Prognostic and Monitoring Biomarker in Multiple Sclerosis
Predicting Cognitive Outcomes from Stroke Based on Lesion Location
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07153-17-0-1
Application #
7574913
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ Johns Hopkins University
$389,122
NIH 2007
N01 HL
Pediatric Hydroxyuera Phase III Clinical Trial
Casella, James F. /
$523,182
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant